Bellicum Pharmaceuticals Inc (BLCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Sales | 185 | 388 | 282 | 1,780 | 1,941 |
| Gross Profit | 185 | 388 | 282 | 1,780 | 1,941 |
| Operating Expenses | 87,572 | 68,768 | 49,417 | 59,618 | 9,863 |
| Operating Income | -87,387 | -68,380 | -49,135 | -57,838 | -7,922 |
| Interest Expense | 3,672 | 1,760 | 12 | 1,791 | 51 |
| Other Income | -720 | 899 | 599 | -24,336 | 4 |
| Pre-tax Income | -91,779 | -69,241 | -48,548 | -83,965 | -7,969 |
| Net Income Continuous | -91,779 | -69,241 | -48,548 | -83,965 | -7,969 |
| Net Income | $-91,779 | $-69,241 | $-48,548 | $-83,965 | $-7,969 |
| EPS Basic Total Ops | -28.90 | -25.70 | -18.40 | -340.40 | -50.50 |
| EPS Basic Continuous Ops | -28.94 | -25.69 | -18.43 | -334.66 | -44.37 |
| EPS Diluted Total Ops | -28.90 | -25.70 | -18.40 | -340.40 | -50.50 |
| EPS Diluted Continuous Ops | -28.94 | -25.69 | -18.43 | -334.66 | -44.37 |
| EPS Diluted Before Non-Recurring Items | -28.40 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-82,747 | $-65,113 | $-47,363 | $-57,171 | $-7,335 |